In the field of oncology research, studies have shown that FSTL1 plays an important role in promoting tumor progression in a variety of tumors, including hepatocellular carcinoma, gastric cancer, colorectal cancer, osteosarcoma and nasopharyngeal carcinoma [7, 9, 37–39]. This evidence concerns the gene FSTL1 and hepatocellular carcinoma.